within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B02B_VitaminKAndOtherHemostatics.B02BD11_Catridecacog;
model Catridecacog 
   extends Pharmacolibrary.Drugs.ATC.B.B02BD11;

  annotation(Documentation(
    info ="<html><body><p>Catridecacog is a recombinant human coagulation factor XIII A-subunit used in the treatment and prophylaxis of bleeding in patients with congenital factor XIII A-subunit deficiency. It is approved for medical use in several countries and is administered to prevent or treat bleeding events associated with FXIII deficiency.</p><h4>Pharmacokinetics</h4><p>Reported in adult patients with congenital factor XIII A-subunit deficiency after intravenous administration of 35 IU/kg single dose.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Catridecacog;
